Jeffrey Pott - AstraZeneca PLC G Officer
| ZEGA Stock | EUR 63.50 1.00 1.60% |
Insider
Jeffrey Pott is G Officer of AstraZeneca PLC
| Phone | 44 20 3749 5000 |
| Web | https://www.astrazeneca.com |
AstraZeneca PLC Management Efficiency
The company has return on total asset (ROA) of 0.0555 % which means that it generated a profit of $0.0555 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0863 %, meaning that it generated $0.0863 on every $100 dollars invested by stockholders. AstraZeneca PLC's management efficiency ratios could be used to measure how well AstraZeneca PLC manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Masakuni Shinozaki | Meiko Electronics Co | 71 | |
| Richard Buskirk | Laureate Education | 46 | |
| Gerard Knauer | Laureate Education | 47 | |
| Yoshihito Kikyo | Meiko Electronics Co | 68 | |
| Richard III | Laureate Education | 53 | |
| Kathleen McNally | Richardson Electronics | 63 | |
| Edward Richardson | Richardson Electronics | 81 | |
| Robert Ben | Richardson Electronics | 58 | |
| Wendy Diddell | Richardson Electronics | 58 | |
| Marcelo Cardoso | Laureate Education | 51 | |
| Luis Novelo | Laureate Education | N/A | |
| Jens Ruppert | Richardson Electronics | 51 | |
| Eilif SerckHanssen | Laureate Education | 57 | |
| Yuichiro Naya | Meiko Electronics Co | 80 | |
| Adam Morse | Laureate Education | N/A | |
| Atsushi Sakate | Meiko Electronics Co | 50 | |
| Gregory Peloquin | Richardson Electronics | 59 | |
| Adam Smith | Laureate Education | N/A | |
| Leslie Brush | Laureate Education | N/A | |
| Junya Wada | Meiko Electronics Co | 62 | |
| Christopher Marshall | Richardson Electronics | N/A | |
Management Performance
| Return On Equity | 0.0863 | |||
| Return On Asset | 0.0555 |
AstraZeneca PLC Leadership Team
Elected by the shareholders, the AstraZeneca PLC's board of directors comprises two types of representatives: AstraZeneca PLC inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AstraZeneca. The board's role is to monitor AstraZeneca PLC's management team and ensure that shareholders' interests are well served. AstraZeneca PLC's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AstraZeneca PLC's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Marc Dunoyer, CEO Officer | ||
| Chris Sheldon, Head Relations | ||
| Pam Cheng, EVP Board | ||
| MBA DVM, CEO Director | ||
| Gonzalo Vina, Head Relations | ||
| Aradhana MD, CFO Director | ||
| Menelas Pangalos, EVP Board | ||
| Katarina Ageborg, Chief Sustainability | ||
| Jeffrey Pott, G Officer | ||
| Ruud Dobber, Exec Unit |
AstraZeneca Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is AstraZeneca PLC a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0863 | |||
| Return On Asset | 0.0555 | |||
| Profit Margin | 0.07 % | |||
| Operating Margin | 0.20 % | |||
| Current Valuation | 228.75 B | |||
| Shares Outstanding | 3.1 B | |||
| Shares Owned By Insiders | 0.04 % | |||
| Shares Owned By Institutions | 17.72 % | |||
| Price To Earning | 45.09 X | |||
| Price To Book | 6.10 X |
Currently Active Assets on Macroaxis
Other Information on Investing in AstraZeneca Stock
AstraZeneca PLC financial ratios help investors to determine whether AstraZeneca Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AstraZeneca with respect to the benefits of owning AstraZeneca PLC security.